These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19472409)
1. LRRK2 gene variation and its contribution to Parkinson disease. Paisán-Ruiz C Hum Mutat; 2009 Aug; 30(8):1153-60. PubMed ID: 19472409 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Paisán-Ruíz C; Nath P; Washecka N; Gibbs JR; Singleton AB Hum Mutat; 2008 Apr; 29(4):485-90. PubMed ID: 18213618 [TBL] [Abstract][Full Text] [Related]
3. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
4. Lrrk2 pathogenic substitutions in Parkinson's disease. Mata IF; Kachergus JM; Taylor JP; Lincoln S; Aasly J; Lynch T; Hulihan MM; Cobb SA; Wu RM; Lu CS; Lahoz C; Wszolek ZK; Farrer MJ Neurogenetics; 2005 Dec; 6(4):171-7. PubMed ID: 16172858 [TBL] [Abstract][Full Text] [Related]
5. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369 [TBL] [Abstract][Full Text] [Related]
6. LRRK2 mutations in Parkinson disease. Farrer M; Stone J; Mata IF; Lincoln S; Kachergus J; Hulihan M; Strain KJ; Maraganore DM Neurology; 2005 Sep; 65(5):738-40. PubMed ID: 16157908 [TBL] [Abstract][Full Text] [Related]
7. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990 [TBL] [Abstract][Full Text] [Related]
9. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8. Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834 [TBL] [Abstract][Full Text] [Related]
10. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of LRRK2 mutations in patients with Parkinson disease. Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110 [TBL] [Abstract][Full Text] [Related]
12. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909 [TBL] [Abstract][Full Text] [Related]
13. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian. Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197 [TBL] [Abstract][Full Text] [Related]
14. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants. Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106 [TBL] [Abstract][Full Text] [Related]